Stay updated on Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Sign up to get notified when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 released, replacing v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:41:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page history now shows Revision: v3.4.1 replacing v3.4.0, indicating a minor update to the study details page.
    Difference
    0.1%
    Check dated 2026-02-04T22:42:01.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The study page now includes a 'Show glossary' option and new metadata fields: 'Last Update Submitted that Met QC Criteria' and the revision label 'v3.4.0'. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data' and revision 'v3.3.4' have been removed.
    Difference
    0.2%
    Check dated 2026-01-28T20:06:42.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Patch note updated to Revision: v3.3.4; the previous Revision: v3.3.3 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:20:32.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Beijing Municipality was added to the Locations section, replacing the former 'Beijing Municipality Locations' listing, and the page revision was updated to v3.3.3 with the HHS Vulnerability Disclosure link removed.
    Difference
    0.2%
    Check dated 2025-12-23T20:50:32.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:13:04.000Z thumbnail image

Stay in the know with updates to Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.